Comparison of clinical outcomes of transjugular intrahepatic portosystemic shunt for refractory ascites and recurrent nonrefractory ascites

doi:10.4254/wjh.v17.i2.100451

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-4)

Sum=0

Feb 27, 2025 (publication date) through Feb 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Feb 27, 2025; 17(2): 100451
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.100451

Full Size Figure Download Figure

Figure 2 Survival rate in the four groups of patients. The 6 months, 1-, 2- , and 3-year survival rates differed significantly between group A and B, group C and D.

Citation: Luo SH, Zhang HF, Liu W, Chu JG, Chen JY. Comparison of clinical outcomes of transjugular intrahepatic portosystemic shunt for refractory ascites and recurrent nonrefractory ascites. World J Hepatol 2025; 17(2): 100451
URL: https://www.wjgnet.com/1948-5182/full/v17/i2/100451.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i2.100451